Gene · 57823
Papers3,217
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,217
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mass Spectrometry Proteomics: A Key to Faster Drug Discovery. | J Med Chem | 2026 | 41433248 | PubTator, text mining | PubMed |
| 2025 Update of Cellular Immunotherapy for Plasma Cell Disorders. | Turk J Haematol | 2026 | 41428622 | PubTator, text mining | PubMed |
| Associations between plasma proteins and psychological wellbeing: evidence from over 20 years of the English Longitudinal Study of Ageing. | Mol Psychiatry | 2026 | 41398370 | PubTator, text mining | PubMed |
| Targeting phagocytosis checkpoints for cancer immunotherapy. | Nat Rev Cancer | 2026 | 41360986 | PubTator, text mining | PubMed |
| GPR56 Outperforms CD319 as a Discriminative Marker for CD4 + Cytotoxic T Lymphocytes and Is Elevated in Primary Sjögren's Syndrome. | Immunology | 2026 | 41324175 | PubTator, text mining | PubMed |
| Identification of therapeutic targets for giant cell arteritis through integrated analysis of multi-omics datasets. | Hepatobiliary Pancreat Dis Int | 2026 | 41318344 | PubTator, text mining | PubMed |
| scPER: A Rigorous Computational Approach to Determine Cellular Subtypes in Tumors Aligned With Cancer Phenotypes From Total RNA Sequencing. | Adv Sci (Weinh) | 2026 | 41309494 | PubTator, text mining | PubMed |
| DNA methylation profiling of human CD4+ T helper cells reveals the epigenetic control of SLAMF7 expression in IFN-γ producing cells. | Immunol Cell Biol | 2026 | 41187703 | PubTator, text mining | PubMed |
| Density of tertiary lymphoid structures predict clinical outcome in hepatoblastoma. | Pediatr Res | 2026 | 40634689 | PubTator, text mining | PubMed |
| Identification of CD320, SLC44A1 and TNFRSF13B as potential novel therapeutic targets for CAR T-cell therapy in multiple myeloma. | Front Med (Lausanne) | 2025 | 41608427 | PubTator, text mining | PubMed |
| Editorial: Enhancing CAR T-cell therapy with imaging. | Front Immunol | 2025 | 41445757 | PubTator, text mining | PubMed |
| Rare CD138 negative plasma cell leukemia with pleomorphic morphology-CD319 to the rescue when traditional markers fail. | J Hematop | 2025 | 41420682 | PubTator, text mining | PubMed |
| RVd and CyBorD therapies remodel B-cell maturation signaling and alter immune and clonal architecture in multiple myeloma. | Cancer Biol Ther | 2025 | 41410549 | PubTator, text mining | PubMed |
| State of the Art of CAR-NK Cell Therapy in Multiple Myeloma: A Comprehensive Review of Cell Sources and Target Antigens. | Int J Mol Sci | 2025 | 41303706 | PubTator, text mining | PubMed |
| Evolution of pneumococcal serotype 19A in children in Bangladesh: insights from genomic analysis. | BMC Microbiol | 2025 | 41286605 | PubTator, text mining | PubMed |
| SLAMF7: A Potential Target for CAR T-Cell Therapy in Multiple Myeloma. | Cancers (Basel) | 2025 | 41228264 | PubTator, text mining | PubMed |
| Identification of gene modules associated with B cell activation and tissue remodeling in primary Sjögren's syndrome. | BMC Immunol | 2025 | 41204409 | PubTator, text mining | PubMed |
| Profiling the Cerebrospinal Fluid Proteome in Progressive Multiple Sclerosis: Treatment Effects and Associations with IgM Oligoclonal Bands. | J Neuroimmune Pharmacol | 2025 | 41165937 | PubTator, text mining | PubMed |
| Management of relapsed refractory multiple myeloma: Evidence-based guide to community oncologists. | Blood Rev | 2025 | 41027761 | PubTator, text mining | PubMed |
| Mechanisms of Resistance to CAR T-Cells and How to Overcome Them. | Methods Protoc | 2025 | 40981226 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/57823/papers?page=3